Cystagon

Active Ingredient(s): Cysteamine
FDA Approved: * August 15, 1994
Pharm Company: * MYLAN
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cystagon Overview

Cysteamine is a medication intended for a number of indications, and approved by the FDA to treat cystinosis. It is a stable aminothiol, i.e., an organic compound containing both an amine and a thiol functional groups. Cysteamine is a white, water-soluble solid. It is often used as salts of the ammonium derivative [HSCH2CH2NH3]+[1] including the hydrochloride, phosphocysteamine, and bitartrate.[2] Cysteamine molecule is biosynthesized in mammals, including hu...

Read more Cystagon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cysteamine

Recent Cystagon Forums:

Possible Dosages for this and Related Drugs:

NDC Database Records for Cystagon: (2 results)

Sorted by National Drug Code

• 0378-9040 Cystagon 50 mg Oral Capsule by Mylan Pharmaceuticals Inc.
• 0378-9045 Cystagon 150 mg Oral Capsule by Mylan Pharmaceuticals Inc.

Other drugs which contain Cysteamine or a similar ingredient: (3 results)

• CYSTARAN Cysteamine
• CYSTEAMINE
• PROCYSBI Cysteamine Bitartrate